Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

This Dividend King Could Be One of the Safest Stocks to Own Right Now

Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock.

Barchart

Trump DOJ Drops Corporate Crime Investigations, Giving Major Companies a Free Pass

The Trump Justice Department has dropped several high-profile corporate investigations, including an inquiry into Federal Reserve Chair Jerome Powell, fueling concerns over a pullback in enforcement.

International Business Times UK

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street

Abbott's Q2 results show solid organic growth, better-than-expected margins, and improved earnings guidance, easing concerns over the Exact Sciences acquisition and boosting ABT shares.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised

Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.

The Economic Times

Infant Formula Makers Were Required to Tell the FDA When Babies Died — Records Show They Never Did

KFF Health News found the FDA received zero formula maker death notifications going back to 2000. Abbott's expert testified it never reported a single death for preterm formula.

Medical Daily

Premature Infants in NICUs Face a Higher Risk of NEC from Formula, Experts Warn

If your premature baby is in the NICU on cow's milk formula, ask about NEC risk now. Here are the specific questions to ask your neonatologist and what the evidence shows.

Medical Daily

Abbott Laboratories Federal Formula Safety Probe Quietly Shelved Following Massive Cash Injection To Donald Trump Fund

The US Justice Department has ended its criminal investigation into Abbott Laboratories' contaminated baby formula plant, opting for civil penalties instead, amid scrutiny over political donations.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

DOJ Dropped Secret Criminal Charges Against Baby Formula Giant Abbott Despite Claims Contaminated Milk 'Sickened And Killed' Infants

The Justice Department has closed its criminal investigation into Abbott Laboratories, opting for civil penalties over charges related to the 2022 baby formula contamination and shortage.

International Business Times UK

Abbott Laboratories' Q2 2026 Earnings: What to Expect

Abbott Laboratories is scheduled to report its second-quarter results in July, and analysts expect a single-digit earnings rise.

Barchart

Ultrahuman seeks to define: M2 Live keeps your metabolic health close with a small sensor

Ultrahuman launches M2 Live with Abbott's Lingo biosensor to help users take their glucose (metabolic health) more seriously with a continuous monitor.

Android Central

Hate giving blood? Samsung’s latest VR demo will help you meditate while donating — and it’s given me some ideas

Samsung’s XR headset might help you relax the next time you give blood, thanks to VR meditation.

TechRadar

MiniMed Group Q4 Earnings Call Highlights

MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first earnings call as a standalone public company following its March IPO. Chief Executive Officer Que Dallar

MarketBeat

3 Ultra-Reliable Dividend Kings Trading at Bargain-Basement Prices

These beaten-down Dividend Kings, trading near their 2026 lows, offer income, rebound potential, and Wall Street-backed upside for patient investors.

Barchart

Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity

While ABT stock appears poised to reach the year’s halfway mark in ignominy, the options market is quietly signaling a possible recovery.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Gen X is the most indebted generation in America. Their employers can fix that

Student loan matching programs are on the books. Does your company have one?

MarketBeat

Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell

See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.

The Guardian - US

What to know about Kyle Diamantas, the new acting FDA commissioner

The ex-lawyer who Trump described as ‘very talented’ was previously deputy commissioner for food at the FDA

Barchart

Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer

Abbott’s business and dividend story remain intact even as the stock trades near 52‑week lows.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA finds US infant formula supply is ‘safe’ after examining 300 samples in Operation Stork Speed

The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project

The Independent UK

US infant formula supply is 'safe,' FDA says after looking for potential contaminants

Federal health officials said a new analysis of U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants

Barchart

This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio

Abbott Labs is a balance of income and growth.

MarketBeat

Abbott Stock Crash: Rebound Could Be Coming Fast

Abbott Laboratories' stock price sell-off is overextended in mid-April, creating an opportunity that income investors will not want to miss.

MarketBeat

A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?

Abbott Laboratories' recent stock price dip contrasts with its strong Medical Devices division, creating a noteworthy opportunity for dividend investors.

Barchart

Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?

Johnson & Johnson offers scale and stability, but Abbott’s cheaper valuation, higher yield, and stronger upside make it the more attractive pick now.

Barchart

Buy the Dip: These 3 Over-$100 Stocks Just Hit New 52-Week Lows

Among the 128 new 52-week lows on the NYSE on Tuesday, there were five with share prices of $100 or higher. Not all of them are worth buying on the dip. We rate three that could be.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

350 stories

Abbott

333 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.